STAT

Opinion: Fixing health care’s replication crisis is important for researchers and patients

We are awash in reports of new study results, from a potential cure for an illness or the latest take on what makes a healthy diet. But are we getting…

We are awash in articles reporting new study results. Whether it’s a potential cure for an illness, daunting statistics about health care outcomes, or the latest take on what makes a healthy diet, we’re receiving more information than we’ve ever had before nudging us toward making decisions about our health.

But are we getting accurate information?

Dr. John Ioannidis, a statistician and professor of medicine at Stanford, recently joined three dozen health researchers in a Stanford lecture hall to explain why most research findings are false. Of the most widely cited health research studies of the last decade, he found that could be replicated, and by later studies.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
STAT1 min read
Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

Related Books & Audiobooks